These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
305 related items for PubMed ID: 33027823
1. Evaluation and Docking Study of Pyrazine Containing 1, 3, 4-Oxadiazoles Clubbed with Substituted Azetidin-2-one: A New Class of Potential Antimicrobial and Antitubercular. Das R, Mehta DK. Drug Res (Stuttg); 2021 Jan; 71(1):26-35. PubMed ID: 33027823 [Abstract] [Full Text] [Related]
3. Boulton-Katritzky Rearrangement of 5-Substituted Phenyl-3-[2-(morpholin-1-yl)ethyl]-1,2,4-oxadiazoles as a Synthetic Path to Spiropyrazoline Benzoates and Chloride with Antitubercular Properties. Kayukova L, Vologzhanina A, Praliyev K, Dyusembaeva G, Baitursynova G, Uzakova A, Bismilda V, Chingissova L, Akatan K. Molecules; 2021 Feb 12; 26(4):. PubMed ID: 33673047 [Abstract] [Full Text] [Related]
7. Synthesis, biological screening and in silico studies of new N-phenyl-4-(1,3-diaryl-1H-pyrazol-4-yl)thiazol-2-amine derivatives as potential antifungal and antitubercular agents. Nandurkar Y, Bhoye MR, Maliwal D, Pissurlenkar RRS, Chavan A, Katade S, Mhaske PC. Eur J Med Chem; 2023 Oct 05; 258():115548. PubMed ID: 37307623 [Abstract] [Full Text] [Related]
16. New quinolinyl-1,3,4-oxadiazoles: synthesis, in vitro antibacterial, antifungal and antituberculosis studies. Patel RV, Kumari P, Chikhalia KH. Med Chem; 2013 Jun 01; 9(4):596-607. PubMed ID: 22921108 [Abstract] [Full Text] [Related]
17. Identification and development of 2,5-disubstituted oxadiazole as potential candidate for treatment of XDR and MDR tuberculosis. Bakal RL, Gattani SG. Eur J Med Chem; 2012 Jan 01; 47(1):278-82. PubMed ID: 22088956 [Abstract] [Full Text] [Related]